• OPEN AN ACCOUNT
Indian Indices
Sensex
72,403.32 478.64
( 0.67%)
Global Indices
Nasdaq
51,875.59 199.64
(0.39%)
Dow Jones
7,829.18 -3.36
(-0.04%)
Hang Seng
69,084.74 42.63
(0.06%)
Nikkei 225
10,644.02 91.97
(0.87%)
Forex
USD-INR
96.46 -0.32
(-0.33%)
EUR-INR
108.04 -0.35
(-0.32%)
GBP-INR
127.62 -0.24
(-0.19%)
JPY-INR
0.61 0.00
(-0.50%)

EQUITY - MARKET SCREENER

Alembic Pharmaceuticals Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
533573
INE901L01018
285.6722314
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
APLLTD
19.62
15482.29
EPS(TTM)
Face Value()
Div & Yield %
40.14
2
1.52
 

modern engineering & projects limited
Rajratan Global Wire records PAT of Rs 15.43 crore in Q4
Apr 22,2026

Total operating expenditure for the period under review was Rs 285.69 crore, up 31% YoY. This was due to higher raw material costs (up 19.7% YoY) and higher other expenses (up 44% YoY).

Profit before tax in Q4 FY26 stood at Rs 17.73 crore, down by 11.6% from Rs 20.06 crore in Q4 FY25.

For FY26, the company has reported net profit and revenue of Rs 70.11 crore (up 19.2% YoY) and Rs 1,156.50 crore (up 23.7% YoY), respectively.

Rajratan Global Wire is engaged in the manufacturing of bead wire, a high-carbon steel wire utilized in the production of tires.